Three New Studies Presented at San Antonio Breast Cancer Symposium Further Demonstrate Value of MammaPrint® and BluePrint® in Individualizing Treatment for Breast Cancer Patients
USA and the Netherlands, December 14, 2016 – Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, highlights new data…